Orris

Alkaptonuria

Reading File
Finding Sources
Searching PubMed

alkaptonuria

Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Reading File
Loading Image
Finding Sources
I now have comprehensive information from multiple authoritative textbooks plus recent PubMed evidence. Here is the complete answer:

Alkaptonuria

Historical Significance

Alkaptonuria holds a unique place in medicine: it was the first "inborn error of metabolism" described in medical literature, documented by Sir Archibald Garrod in 1896 - who famously called it "a rather harmless disease." That characterization has since been substantially revised. - Rheumatology, 2-Volume Set (Elsevier, 2022)

Genetics & Biochemistry

FeatureDetail
InheritanceAutosomal recessive (AR)
GeneHGD (chromosome 3q13.33)
Enzyme defectHomogentisate 1,2-dioxygenase (homogentisic acid oxidase)
Metabolic pathwayTyrosine / phenylalanine catabolism
Incidence~1 : 250,000 births
Sex ratioMales outnumber females 2:1
The HGD enzyme normally cleaves the aromatic ring of homogentisic acid (HGA) in the liver and kidney. Without it, HGA accumulates in blood, is excreted in massive amounts in urine, and deposits as oxidized black-brown pigment (benzoquinone acetate polymer) in connective tissues - the condition called ochronosis. - Lippincott Illustrated Reviews: Biochemistry, 8th ed.; Emery's Elements of Medical Genetics and Genomics

Pathophysiology

Phenylalanine / Tyrosine
        ↓
  4-Hydroxyphenylpyruvate
        ↓  (inhibited by nitisinone)
  Homogentisic acid (HGA)
        ↓  ← [HGD enzyme BLOCKED in alkaptonuria]
  Maleylacetoacetate → Fumarate + Acetoacetate
Accumulated HGA polymerizes upon oxidation into dark ochronotic pigment that:
  1. Deposits in collagen-rich tissues (cartilage, tendons, ligaments, heart valves, skin)
  2. Makes cartilage brittle and mechanically fragile
  3. Promotes local pyrophosphate accumulation, accelerating joint destruction

Clinical Features (Timeline)

Infancy / Childhood

  • Dark staining of diapers - the earliest clue
  • Urine darkens on standing or with alkalization (HGA oxidizes to black pigment)
  • Generally asymptomatic
Urine from a patient with alkaptonuria - showing progressive darkening (at 15 min on left, entirely black at 2 hours on right):
Alkaptonuria urine specimens and affected vertebrae

3rd Decade (ages 20-30)

  • Pigmentation appears in the sclera (Osler sign - grey-brown deposits, usually lateral to the cornea) and ear cartilage (concha, antihelix, helix)
  • Black cerumen (ear wax)
  • Skin: blue/brown macules on fingers, ears, nose, axillae, buccal mucosa
Osler sign - scleral pigmentation:
Osler sign - ochronotic scleral pigmentation in alkaptonuria
Auricular pigmentation:
Blue-black discoloration of the ear cartilage in alkaptonuria

4th-5th Decade (30-50 years)

  • Ochronotic arthropathy - the dominant disabling feature
    • Spine involved first: low back pain starting ages 30-40, progressive thoracic kyphosis mimicking ankylosing spondylitis
    • Large joints follow: knees, shoulders, hips
    • Small peripheral joints are typically spared
    • Synovial fluid: noninflammatory; may contain tiny fragments of pigmented cartilage ("ground pepper" sign)
    • Tendon ruptures may occur
  • Cardiac involvement: HGA deposits in aortic and mitral valves; aortic stenosis may require valve replacement (particularly after age 60)
  • Renal/prostatic calculi: pigmented stones from HGA deposition

Radiology

  • Pathognomonic finding: Dense calcification of intervertebral discs (disc space ossification), followed by disc space narrowing and collapse
  • Multiple vacuum discs
  • Distinguishes ochronotic spondylosis from ankylosing spondylitis (the latter does not calcify discs)
  • Harrison's 22E, Goldman-Cecil Medicine, Rheumatology 2022

Diagnosis

TestFinding
Urine organic acid analysisMassive elevation of homogentisic acid - primary diagnostic test
Urine appearanceDarkens to black on standing or alkalinization
HGD gene sequencingConfirms mutation (>300 mutations known)
Synovial fluidNoninflammatory; "ground pepper" ochronotic fragments
Spine X-rayIntervertebral disc calcification (pathognomonic)
Histology (skin)Large irregular ochre bodies in reticular dermis; degenerated elastic fibers stain black with crystal violet or methylene blue

Treatment

Disease-Modifying

  • Nitisinone (NTBC; 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione) - the primary treatment advance
    • Originally a triketone herbicide; used in tyrosinemia type I
    • Mechanism: inhibits 4-hydroxyphenylpyruvate dioxygenase (an upstream enzyme), blocking HGA production entirely
    • Dose: 10 mg/day
    • Effect: dramatically reduces urinary HGA to near-normal levels
    • Caveat: most effective before joint disease is established; less benefit once arthropathy is advanced; can cause tyrosine keratopathy as a side effect (tyrosine levels rise)
    • The SONIA 2 trial (Lancet Diabetes Endocrinol, 2020) was a landmark RCT demonstrating efficacy in reducing HGA
  • Dietary restriction of phenylalanine and tyrosine: reduces HGA substrate load, but does not reliably prevent disease progression

Symptomatic / Surgical

  • Analgesics and NSAIDs for arthritis pain
  • Joint replacement (hip, knee arthroplasty) for advanced ochronotic arthritis
  • Spinal surgery when indicated
  • Cardiac valve replacement (aortic/mitral) when valvular disease is severe

Key Differentials

  • Ankylosing spondylitis: axial disease, HLA-B27+, sacroiliitis, no disc calcification, no darkening urine
  • Exogenous ochronosis: topical hydroquinone use (skin lightening agents) causes similar skin pigmentation but no systemic features
  • Rheumatoid arthritis: small joint involvement, seropositive, erosive; unlike ochronotic arthritis

Recent Evidence

A 2025 systematic review with meta-analysis (PMID 40157162) confirmed the efficacy and safety of nitisinone for alkaptonuria. A comprehensive 2024 Nature Reviews Disease Primers review (PMID 38453957) provides updated understanding of pathophysiology and disease staging. A 2025 review on ochronotic arthropathy (PMID 40071956) details orthopedic management strategies.

Summary Mnemonics

"DARK URINE + DARK JOINTS + DARK EARS = Alkaptonuria"
Enzyme: Homogentisate 1,2-dioxygenase (HGD gene) Substrate: Homogentisic acid (HGA) Inheritance: Autosomal Recessive Treatment: Nitisinone (blocks upstream HGA synthesis)
Sources: Harrison's Principles of Internal Medicine 22E | Goldman-Cecil Medicine | Rheumatology 2-Volume Set (Elsevier 2022) | Andrews' Diseases of the Skin 11e | Lippincott Illustrated Reviews: Biochemistry 8e | Emery's Elements of Medical Genetics and Genomics
This is a shared conversation. Sign in to Orris to start your own chat.